Squarepoint
VYGR icon

Squarepoint’s Voyager Therapeutics VYGR Stock Holding History

Squarepoint’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38,650
Closed -$219K – 5499
2024
Q4 		$219K Sell
38,650
-32,074
-45% -$207K ﹤0.01% 4402
2024
Q3 		$414K Buy
+70,724
New +$514K ﹤0.01% 3242
2023
Q4 		– Sell
-31,181
Closed -$242K – 4560
2023
Q3 		$242K Buy
31,181
+20,506
+192% +$187K ﹤0.01% 3298
2023
Q2 		$122K Sell
10,675
-32,526
-75% -$336K ﹤0.01% 3326
2023
Q1 		$333K Buy
+43,201
New +$344K ﹤0.01% 2514
2022
Q2 		– Sell
-20,066
Closed -$153K – 3427
2022
Q1 		$153K Buy
20,066
+5,248
+35% +$23.4K ﹤0.01% 2542
2021
Q4 		$40K Sell
14,818
-18,439
-55% -$62.9K ﹤0.01% 3052
2021
Q3 		$87K Sell
33,257
-54,703
-62% -$178K ﹤0.01% 2698
2021
Q2 		$363K Buy
87,960
+73,731
+518% +$334K ﹤0.01% 2382
2021
Q1 		$67K Buy
+14,229
New +$97K ﹤0.01% 2967
2020
Q1 		– Sell
-127,179
Closed -$1.77M – 2570
2019
Q4 		$1.77M Sell
127,179
-19,591
-13% -$285K 0.01% 981
2019
Q3 		$2.53M Buy
+146,770
New +$3.08M 0.02% 755
2019
Q1 		– Sell
-34,983
Closed -$329K – 2462
2018
Q4 		$329K Buy
34,983
+19,883
+132% +$255K ﹤0.01% 1460
2018
Q3 		$286K Sell
15,100
-3,700
-20% -$71K ﹤0.01% 1564
2018
Q2 		$367K Buy
+18,800
New +$372K ﹤0.01% 1302
2018
Q1 		– Sell
-13,768
Closed -$229K – 2186
2017
Q4 		$229K Buy
+13,768
New +$236K ﹤0.01% 1720

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint's VYGR Position: Q1 2025 in Review

Squarepoint sold out of Voyager Therapeutics (VYGR) in Q1 2025, closing a stake of 38,650 shares — an estimated $219K sold.

Squarepoint first reported a position in VYGR in Q4 2017 and held it in 16 quarters. The position peaked at $2.53M in Q3 2019. 116 funds tracked by Wall St. Rank hold VYGR as of Q1 2025.

  • Squarepoint reported no remaining Voyager Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Squarepoint sold 38,650 Voyager Therapeutics shares in Q1 2025, an estimated $219K.
  • Squarepoint first reported a position in Voyager Therapeutics in Q4 2017 and held it in 16 quarters.
  • Squarepoint's Voyager Therapeutics position peaked at $2.53M in Q3 2019.
  • 116 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2025.

Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.